Paper: Final Results of the Fibromet Trial: An Open Label Phase II Study to Evaluate Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients -

Oral and Poster Abstracts 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II Clinical Trials, Clinical Research, Diseases, Myeloid Malignancies Paula De Melo Campos, MD, PhD1, Katia B Pagnano, MD, PhD1, Rubia Isler Mancuso, BSc, MSc1*, Fernanda Isabel Della Via, BSc, MSc1*, Ângela Condotta Tinoco, BSc2*, Guilherme Rossi...

DocWire Editors

Final Results of the Fibromet Trial

Read the full article here

See more from DocWire Editors